Literature DB >> 16969671

[Ventricular tachycardia. Diagnostic spectrum and therapeutic measures].

T Lewalter1, J O Schwab, G Nickenig.   

Abstract

The origin of ventricular tachycardia lies in the ventricular tissue and includes a variety of symptoms such as monomorphic and polymorphic ventricular tachyarrhythmia (VT), ventricular flutter and ventricular fibrillation. Due to transitions of one form of VT to another, any form of VT incurs in principal the risk of cardiac failure. Apart from different electrophysiologic mechanisms such as reentry or triggered activity, any occurrence of VT has to be considered in an individual context: VT can be caused by structural heart disease such as coronary artery disease or dilative cardiomyopathy, or primary electrical disease such as long or short QT syndromes or can even occur without any detectable cause (idiopathic VT). Correct identification of the underlying cause of the arrhythmia is essential for the prognosis, differential therapy and long-term treatment of patients.

Entities:  

Mesh:

Year:  2006        PMID: 16969671     DOI: 10.1007/s00108-006-1708-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  33 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.

Authors:  Heikki Swan; Päivi Laitinen; Kimmo Kontula; Lauri Toivonen
Journal:  J Cardiovasc Electrophysiol       Date:  2005-02

3.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

4.  Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG.

Authors:  Christian Wolpert; Rainer Schimpf; Carla Giustetto; Charles Antzelevitch; Jonathan Cordeiro; Robert Dumaine; Ramon Brugada; Kui Hong; Urs Bauersfeld; Fiorenzo Gaita; Martin Borggrefe
Journal:  J Cardiovasc Electrophysiol       Date:  2005-01

5.  Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.

Authors:  Paul Dorian; Martin Borggrefe; Hussein R Al-Khalidi; Stefan H Hohnloser; Jose M Brum; Daljit S Tatla; Johannes Brachmann; Robert J Myerburg; David S Cannom; Michael van der Laan; Michael J Holroyde; Igor Singer; Craig M Pratt
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

Review 6.  Exercise-induced ventricular arrhythmias in patients with no structural cardiac disease.

Authors:  Melvin M Scheinman; Jason Lam
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

7.  Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

Authors:  Stuart J Connolly; Paul Dorian; Robin S Roberts; Michael Gent; Steven Bailin; Eric S Fain; Kevin Thorpe; Jean Champagne; Mario Talajic; Benoit Coutu; Gerian C Gronefeld; Stefan H Hohnloser
Journal:  JAMA       Date:  2006-01-11       Impact factor: 56.272

8.  Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study.

Authors:  R Sheldon; S Connolly; A Krahn; R Roberts; M Gent; M Gardner
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

Review 9.  Brugada syndrome: report of the second consensus conference.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Heart Rhythm       Date:  2005-04       Impact factor: 6.343

10.  Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

Authors:  Silvia G Priori; Carlo Napolitano; Peter J Schwartz; Massimiliano Grillo; Raffaella Bloise; Elena Ronchetti; Cinzia Moncalvo; Chiara Tulipani; Alessia Veia; Georgia Bottelli; Janni Nastoli
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

View more
  1 in total

Review 1.  Surgical therapy of ventricular arrhythmias.

Authors:  T Doenst; G Faerber; S Grandinac; T Kuntze; L Menicanti; M A Borger; F W Mohr
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.